➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Express Scripts
Moodys
AstraZeneca
Merck

Last Updated: April 20, 2021

DrugPatentWatch Database Preview

Menotropins (fsh;lh) - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for menotropins (fsh;lh)

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Assiut UniversityN/A
Ferring PharmaceuticalsPhase 3
Hospital de Clinicas de Porto AlegreN/A

See all menotropins (fsh;lh) clinical trials

Recent Litigation for menotropins (fsh;lh)

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC2018-12-19
Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc.2018-05-31
SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP.2017-08-08

See all menotropins (fsh;lh) litigation

Company Disclosures: US Patents for menotropins (fsh;lh)

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ferring MENOPUR menotropins (fsh;lh) INJECTABLE;SUBCUTANEOUS 021663 001 2006-03-20   Start Trial Novo Nordisk A/S (Bagsvaerd, DK) 2014-04-08 RX company
Ferring MENOPUR menotropins (fsh;lh) INJECTABLE;SUBCUTANEOUS 021663 001 2006-03-20   Start Trial Novo Nordisk A/S (Bagsvaerd, DK) 2016-06-20 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for menotropins (fsh;lh)

These patents were identified by searching patent claims

Supplementary Protection Certificates for menotropins (fsh;lh)

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
50/1999 Austria   Start Trial PRODUCT NAME: INSULIN ASPART
C0044 Belgium   Start Trial PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615
90042 Netherlands   Start Trial PRODUCT NAME: INSULIN ASPART; REGISTRATION NO/DATE: EU/1/99/119/001 - EU/1/99/119/005 19990907
C/GB99/045 United Kingdom   Start Trial SPC/GB99/045: 20060829, EXPIRES: 20110828
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
AstraZeneca
McKesson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.